Vyne Therapeutics issues pre-funded warrants for 133,290 shares in stock exchange dealPUBT·Jul 30 at 03:13 PMVYNE0.00%
The Market's Unmapped Edges: What a Basket of Fringe Stocks Reveals About 2026Global Report·Jul 28 at 04:13 AMQHUOD0.00%ASPI+3.26%
Why SAP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarketbenzinga_article·Jul 24 at 03:35 AMAMKR+10.78%LVWR-19.05%
Vyne Therapeutics set for 1-for-50 reverse stock split on July 24PUBT·Jul 23 at 03:50 PMVYNE0.00%YARW+13.96%
VYNE Therapeutics Provides Update Regarding Cash Dividend, Reverse Stock Split and Anticipated Timing of Closing of the Proposed Merger with Yarrow Bioscience | VYNE Stock NewsStockTitan·Jul 23 at 07:26 AMVYNE0.00%YARW+13.96%
VYNE Therapeutics Sets 1-for-50 Reverse Stock Split Ahead Of Yarrow Mergerrttnews·Jul 21 at 07:35 AMVYNE0.00%YARW+13.96%
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga_article·Jul 21 at 07:05 AMZYBT-6.77%IMNN+6.96%
Vyne Therapeutics holds shareholder special meeting on merger proposalsPUBT·Jul 20 at 05:04 AMVYNE0.00%YARW+13.96%
VYNE: YB-101 targets unmet needs in GD and TED with a novel, well-funded, and differentiated approachQuartr·Jul 14 at 05:05 PMVYNE0.00%YARW+13.96%
VYNE Therapeutics declares $0.38/share merger-contingent special dividendbusinessinsider·Jul 13 at 12:00 AMVYNE0.00%YARW+13.96%
